Ostenil syringe 2 ml
In Stock
Medical device for human use
Indication
Pain and restricted mobility in degenerative and traumatic changes of the knee joint and other synovial joints.
Composition
Hyaluronic acid 20 mg in 2 ml syringe. Each ml of Ostenil contains 10 mg of Sodium Hyaluronate. Ostenil contains Sodium chloride, sodium monohydrogenphosphate, sodium dihydrogenphosphate, water for injection as excipients.
Dosage and administration
Depending on the size of the joint inject 2ml or less of OSTENIL® into the joint cavity once a week for 3 to 5 injections. Several joints may be treated at the same time. The beneficial effects of a treatment cycle of five intra-articular injections may last for several months depending on the severity of the joint changes. Repeated treatment cycles may be administered as required. In case of joint effusion it is advisable to reduce the effusion by aspiration, rest, application of an ice pack and/or intra-articular corticosteroid injection. Treatment with OSTENIL® can be started two to three days later.
The contents and outer surface of the OSTENIL® pre-filled syringe are sterile as long as the sterile pack remains unbroken. Take the pre-filled syringe out of the sterile pack, remove the Luer lock cap from the syringe, attach a sterile cannula (19 to 21 G) and secure it by turning slightly. Remove the air bubble from the syringe prior to injection.
